Project Grant R01DK146817
- Federal Grant Award Summary Yale University received a $734,743 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2026 through June 30, 2031. The research project investigates brain dopamine (DA) dynamics in obesity by examining striatal DA responses to nutrient consumption in individuals with normal and elevated body mass index (BMI)....
- Federal Grant Award Summary Yale University received an $802,843 Project Grant award dated September 13, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications," will be conducted through June 30, 2030, at Yale's Connecticut facility. This award funds...
- Federal Grant Award Summary Yale University received a $133,333 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for August 31, 2026. The award funds research aimed at correcting the myeloid bias of aged hematopoietic stem and progenitor cells (HSPCs) by preventing linker histone turnover,...
- Federal Grant Award Summary Yale University received a $3.23 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. The award supports investigator-initiated biomedical research focused on understanding the role of neutrophils in the pathogenesis of cholangiopathies—a group of bile duct diseases...
- Federal Project Grant Award Summary Yale University received a $167,916 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective May 1, 2026, through April 30, 2028, supports basic biomedical research investigating the genetic dysregulation of messenger RNA (mRNA) translation mechanisms in Type 1 Diabetes (T1D). The research focuses on...
- Federal Grant Award Summary Yale University received a $387,748 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through December 31, 2030. The award funds a research initiative to develop and evaluate a patient-centered collaborative care model (COCM) for treating urinary incontinence (UI) among women with obesity and Type 2...
- Federal Grant Award Summary Tufts University School of Medicine received a $735,358 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded May 21, 2026, with completion targeted for February 28, 2030. This research grant funds investigator-initiated basic biomedical research focused on understanding enteroendocrine cell (EEC) dysfunction in obesity and...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Miriam Hospital a Project Grant totaling $111,750 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the project titled "Comprehensive Assessment and Response for Eating Disorders in Type 1 Diabetes (CARE T1D)." The award, dated May 5, 2026, with a completion date of April 30, 2028, supports the development and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $549,602 to University Enterprises Corporation at California State University, San Bernardino under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a three-year project period (May 1, 2026 – April 30, 2029). This Project Grant supports a multimodal research study investigating the neural, psychological, and physiological mechanisms underlying...
- Federal Project Grant Award Summary Award Overview New York University received a $249,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through June 30, 2028. The award supports basic biomedical research investigating the competing neurobiological mechanisms by which hunger-promoting AGRP (Agouti-Related Peptide) neurons and...
Yale University received a $839,770 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 1, 2026, with completion scheduled for February 28, 2031. The award supports research on cognitive and behavioral approaches to reduce binge eating and excess weight in adolescents, addressing binge-eating disorder, which represents the most prevalent eating disorder despite having the lowest treatment rate among formal eating disorders. The research will be conducted at Yale's New Haven, Connecticut facility and is designed to generate evidence-based interventions for this significant public health concern. The project aligns with NIDDK's mission to advance biomedical research that improves understanding of disease mechanisms and leads to enhanced prevention, diagnosis, and treatment approaches. As a Project Grant mechanism supporting investigator-initiated research, this award funds basic and clinical research activities intended to contribute to the scientific foundation necessary for reducing morbidity and mortality associated with metabolic and behavioral disorders in the adolescent population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $839.8k | 5/26/26 |